By Elric Langton | 21 December 2022
I have a financial interest in Poolbeg Pharma.
Poolbeg identifies new potential drug candidates for Respiratory Syncytial Virus infections as part of the Artificial Intelligence Programme.
SPONSORED
Poolbeg Pharma (AIM: POLB, OTCQB: POLBF), a leading infectious disease-focused biopharmaceutical company, announces that it β¦